Melanin in the trabecular meshwork is associated with age, POAG but not Latanoprost treatment. A masked morphometric study

Experimental Eye Research

Volumn 82, Issue 6 SPEC. ISS., 2006, Pages 986-993

  Cracknell, Kathryn P B ^a   Grierson, Ian ^a   Hogg, Penny ^a   Majekodunmi, Ajesola A ^a   Watson, Peter ^a   Marmion, Vincent ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Ageing; Glaucoma; Latanoprost; Melanin; Morphometry; Outflow system; Phagocytosis; Prostaglandins; Trabecular meshwork; Trabeculectomy

Indexed keywords

LATANOPROST; MELANIN;

ADULT; AGED; ARTICLE; CADAVER; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; EYE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MICROSCOPY; MORPHOMETRICS; OPEN ANGLE GLAUCOMA; ORGAN DONOR; PHAGOCYTOSIS; PIGMENTATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TRABECULAR MESHWORK; TRABECULECTOMY;

EID: 33646189469     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.10.009     Document Type: Article

References (41)

1. Alvarado J.A., and Murphy C.G. Outflow obstruction in pigmentary and primary open angle glaucoma. Arch. Ophthalmol. 110 (1992) 1185-1779
2. Arranz-Marquez E., Teus M.A., Saornil M.A., Mendez M.C., and Gil R. Analysis of irises with a latanoprost-induced change in iris color. Am. J. Ophthalmol. 138 (2004) 625-630
3. Bron A.J., Tripathi R.C., and Tripathi B.J. Woolfe's Anatomy of the Eye and Orbit. eighth Ed. (1997), Chapman &Hall, London
4. Buller C., Johnson D.H., and Tschumper R.C. Human trabecular meshwork phagocytosis. Observations in an organ culture system. Invest. Ophthalmol. Vis. Sci. 31 (1990) 2156-2163
5. Camras C.B., Neely D.G., and Weiss E.L. Latanoprost-induced iris color darkening: a case report with long-term follow-up. J. Glaucoma 9 (2000) 95-98
6. Chiba T., Kashiwagi K., Ishijima K., et al. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Jpn. J. Ophthalmol. 48 (2004) 141-147
7. Chou S.Y., Chou C.K., Kuang T.M., and Hsu W.M. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes. Eye 19 (2004) 784-787
8. Christen R., Pache M., Tenchner B., Meyer P., Prunte C., and Flammer J. Iris transillumination defects in patients with primary open angle glaucoma. Eur. J. Ophthalmol. 13 (2003) 365-369
9. Cracknell K.P., Grierson I., Hogg P., Appleton P., and Pfeiffer N. Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies. Exp. Eye Res. 77 (2003) 721-730
10. Farrar S.M., and Shields M.B. Current concepts in pigmentary glaucoma. Surv. Ophthalmol. 37 (1993) 233-252
11. Grierson I. What is open angle glaucoma?. Eye 1 (1987) 15-28
12. Grierson I., and Hogg P. The proliferative and migratory activities of trabecular meshwork cells. Prog. Retin. Eye Res. 15 (1995) 33-67
13. Grierson I., Pfeiffer N., Cracknell K.P.B., and Appleton P. Histology and fine structure of the iris and outflow system following latanoprost therapy. Surv. Ophthalmol. 47 (2002) S176-S184
14. Hara T. Increased iris pigmentation after use of latanoprost in Japanese brown eyes. Nippon Ganka Gakkai Zasshi 105 (2001) 314-321
15. Haynes W.L., Johnson A.T., and Alward W.L.M. Effects of jogging exercise on patients with the pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology 99 (1992) 1096-1103
16. Herndon L.W., Robert D.W., Wand M., and Asrani S. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans. Am. J. Ophthalmol. 135 (2003) 713-715
17. Hogan M.J., Alvarado J.A., and Weddell J.E. Histology of the Human Eye (1971), Saunders, Philadelphia
18. Johnson D.H. Does pigmentation affect the trabecular meshwork?. Arch. Ophthalmol. 107 (1989) 250-254
19. Johnstone M.A. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am. J. Ophthalmol. 124 (1997) 544-547
20. Kuchle M., Mardin C.Y., Nguyen N.X., Wartus P., and Naumann G.O. Quantification of aqueous melanin granules in primary pigment dispersion syndrome. Am. J. Ophthalmol. 126 (1998) 442-445
21. Lee W.R. Doyne lecture. The pathology of the outflow system in primary and secondary glaucoma. Eye 9 (1995) 1-23
22. Lichter P.R., and Shaffer R.N. Diagnostic and prognostic signs in pigmentary glaucoma. Trans. Am. Acad. Ophthalmol. Otolaryngol. 74 (1970) 984-998
23. Lindquist N.G., Larsson B.S., and Stjernschantz J. Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue. Exp. Eye Res. 69 (1999) 431-436
24. Matsumoto Y., and Johnson D.H. Trabecular meshwork phagocytosis in glaucomatous eyes. Ophthalmologica 211 (1997) 147-152
25. Murphy C.G., Johnson M., and Alvarado J.A. Juxtacanalicular tissue in pigmentary and primary open angle glaucoma. Arch. Ophthalmol. 110 (1992) 1779-1785
26. Nakamura Y., Nakamura Y., Morine-Shinjo S., Sakai H., and Sawaguchi S. Assessment of chamber angle pigmentation during longterm latanoprost treatment for open-angle glaucoma. Acta Ophthalmol. Scand. 82 (2004) 158-160
27. Pappas R.M., Pusin S., and Higginbotham E.J. Evidence of early change in iris color with latanoprost use. Arch. Ophthalmol. 116 (1998) 1115-1116
28. Polansky J.R., Wood I.S., Maglio M.T., and Alvarado J.A. Trabecular meshwork cell culture in glaucoma research: evaluation of biological activity and structural properties of human trabecular cells in vitro. Ophthalmology 91 (1984) 580-594
29. Richardson T.M., Hutchinson B.T., and Grant W.M. The outflow tract in pigmentary glaucoma: a light and electron microscopic study. Arch. Ophthalmol. 95 (1977) 1015-1025
30. Robinson C.H., Nopanitaya W., and McPherson S.D. Pigmentary glaucoma: an ultrastructural study. Ann. Ophthalmol. 13 (1981) 49-51
31. Rodriques M.M., Spaeth G.L., Weinreb S., and Sivalingam E. Spectrum of trabecular pigmentation in open-angle glaucoma: a clinicopathologic study. Trans. Am. Acad. Ophthalmol. Otolaryngol. 81 (1976) 258-276
32. Rohen, J.W., Lutjen-Drecoll, E., 1971. Age changes in the trabecular meshwork in human and monkey eyes. In: Aging and Development. Schattaur Verlag Stuttgart, pp. 1-36.
33. Rohen J.W., and Lutjen-Drecoll E. Ageing processes in the anterior segment of the eye. In: Lutjen-Drecoll E., and Rohen J.W. (Eds). Basic Aspects of Glaucoma Research III (1991), Schattauer, Stuttgart 191-224
34. Rohen J.W., and Van der Zypen E. The phagocytic activity of the trabecular meshwork endothelium. Graefe's Arch. Clin. Exp. Ophthalmol. 175 (1968) 143-160
35. Sherwood M.E., and Richardson T.M. Phagocytosis by trabecular meshwork cells: sequence of events in cats and monkeys. Exp. Eye Res. 46 (1988) 881-895
36. Shirato S., Murphy C., Bloom E., Franse-Carman L., Maglio M., Polansky J.R., and Alvarado J. Kinetics of phagocytosis in trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 30 (1989) 2499-2511
37. 2alpha-isopropyl ester to latanoprost: a review of the development of xalatan. The proctor lecture. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1134-1145
38. Teus M.A., Arranz-Marquez E., and Lucea-Suescun P. Incidence of iris colour change in latanoprost treated eyes. Br. J. Ophthalmol. 86 (2002) 1085-1088
39. Wand M., Ritch R., Isbey E.K., and Zimmerman Jr. T.J. Latanoprost and periocular skin color changes. Arch. Ophthalmol. 119 (2001) 614-615
40. Watson P., Sjernschantz J.W., and the latanoprost study group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 103 (1996) 126-137
41. Wistrand P.J., Stjernschantz J., and Olsson K. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. Surv. Ophthalmol. 41 (1997) S129-S138